심장 제세동기 시장 : 제품 유형, 환자 유형, 최종 사용자별 - 세계 예측(2025-2030년)

The Cardiac Defibrillators Market was valued at USD 8.47 billion in 2023, expected to reach USD 9.12 billion in 2024, and is projected to grow at a CAGR of 7.92%, to USD 14.45 billion by 2030.

Cardiac defibrillators are medical devices designed to deliver a therapeutic dose of electrical energy to the heart affected by life-threatening cardiac dysrhythmias, specifically ventricular fibrillation and ventricular tachycardia. This equipment is vital within the medical field for both emergency response situations and long-term patient management, particularly in hospitals and for at-risk patients at home. The end-use scope spans hospitals, pre-hospital emergency units, and individual patients, with applications in both urban and rural medical settings. Key factors influencing growth in this market include rising incidences of cardiovascular diseases, technological advancements in defibrillation technology, and increasing awareness about heart health. Opportunities exist particularly in the growing acceptance of automated external defibrillators (AEDs) in public settings, expansion into emerging markets with unmet healthcare needs, and integration of IoT for real-time monitoring and data collection. However, the market faces challenges such as stringent regulatory approvals, high costs of devices, and the need for professional training to use defibrillators effectively. Limitations also stem from the potential for technology obsolescence as rapid advancements occur, requiring continuous investment in R&D. The competitive marketplace demands innovation, with opportunities lying in developing more compact, user-friendly, and cost-effective models, as well as in improving battery life and connectivity features. Research into AI and machine learning to predict and personalize defibrillation therapy could prove revolutionary. Market players should focus on partnerships with healthcare providers and public health organizations to enhance market penetration. The nature of the defibrillator market is dynamic, with a leaning towards value-based healthcare delivery, emphasizing effectiveness and patient outcomes. Staying attuned to regulatory changes and patient needs while fostering innovation will be essential for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Defibrillators Market

The Cardiac Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiac arrhythmias and sudden cardiac arrest (SCA) cases
  • Government initiatives to improve emergency medical response systems
  • Growing adoption of implantable cardioverter-defibrillators (ICDs)
• Market Restraints
  • Limited awareness among the general public about cardiac defibrillators
• Market Opportunities
  • Ongoing advancements in cardiac defibrillator technologies
  • Expansion of public access cardiac defibrillation programs
• Market Challenges
  • Limited availability of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Defibrillators Market

A detailed market share analysis in the Cardiac Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Defibrillators Market

A strategic analysis of the Cardiac Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI Italia S.r.l., Apex Medical Systems, Baxter International Inc., Bexen Cardio, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CU Medical Systems, GE HealthCare Technologies Inc., Koninklijke Philips N.V., LivaNova PLC, Mediana Co., Ltd., Medtonic PLC, Metsis Medikal, MicroPort Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., Vivan Meditech, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Transvenous Implantable Cardioverter Defibrillators, and Wearable Cardioverter Defibrillators.
• Based on Patient Type, market is studied across Adult and Pediatrics.
• Based on End-user, market is studied across Clinics & Cardiac Centers, Home Healthcare, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiac arrhythmias and sudden cardiac arrest (SCA) cases
    • 5.1.1.2. Government initiatives to improve emergency medical response systems
    • 5.1.1.3. Growing adoption of implantable cardioverter-defibrillators (ICDs)
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness among the general public about cardiac defibrillators
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in cardiac defibrillator technologies
    • 5.1.3.2. Expansion of public access cardiac defibrillation programs
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Defibrillators Market, by Product

• 6.1. Introduction
• 6.2. Implantable Cardioverter Defibrillators
• 6.3. Subcutaneous Implantable Cardioverter Defibrillators
• 6.4. Transvenous Implantable Cardioverter Defibrillators
• 6.5. Wearable Cardioverter Defibrillators

7. Cardiac Defibrillators Market, by Patient Type

• 7.1. Introduction
• 7.2. Adult
• 7.3. Pediatrics

8. Cardiac Defibrillators Market, by End-user

• 8.1. Introduction
• 8.2. Clinics & Cardiac Centers
• 8.3. Home Healthcare
• 8.4. Hospital

9. Americas Cardiac Defibrillators Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiac Defibrillators Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Defibrillators Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMI Italia S.r.l.
• 3. Apex Medical Systems
• 4. Baxter International Inc.
• 5. Bexen Cardio
• 6. BIOTRONIK SE & Co. KG
• 7. Boston Scientific Corporation
• 8. CU Medical Systems
• 9. GE HealthCare Technologies Inc.
• 10. Koninklijke Philips N.V.
• 11. LivaNova PLC
• 12. Mediana Co., Ltd.
• 13. Medtonic PLC
• 14. Metsis Medikal
• 15. MicroPort Scientific Corporation
• 16. Narang Medical Limited
• 17. Nihon Kohden Corporation
• 18. Progetti Srl
• 19. Schiller AG
• 20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 21. Stryker Corporation
• 22. Thermo Fisher Scientific Inc.
• 23. Vivan Meditech
• 24. ZOLL Medical Corporation by Asahi Kasei Corporation